STAT3/p-STAT3 expression is correlated with clinicopathological characteristics and prognosis in non-small cell lung cancer
View abstract on PubMed
Summary
This summary is machine-generated.Signal transducer and activator of transcription factor 3 (STAT3) and its phosphorylated form (p-STAT3) are upregulated in non-small cell lung cancer. p-STAT3 correlates with age and pathology, suggesting its potential as a biomarker.
Area Of Science
- Oncology
- Molecular Biology
- Biomarker Discovery
Background
- Signal transducer and activator of transcription factor 3 (STAT3) is implicated in tumorigenesis.
- Prognostic significance of STAT3/p-STAT3 in non-small cell lung cancer (NSCLC) remains underexplored.
Purpose Of The Study
- To investigate the prognostic value of STAT3 and phosphorylated STAT3 (p-STAT3) in NSCLC.
- To determine the association of STAT3/p-STAT3 expression with clinical characteristics and patient survival.
Main Methods
- Immunohistochemistry was used to assess STAT3/p-STAT3 expression in 239 NSCLC tissues and 71 normal lung tissues.
- Statistical analyses included Pearson's Chi-squared test and Kaplan-Meier survival analysis.
Main Results
- STAT3/p-STAT3 was significantly upregulated in NSCLC tissues compared to normal tissues (p<0.001).
- p-STAT3 expression correlated with patient age (p=0.046) and pathological types (p=0.037).
- STAT3 positivity was associated with poorer survival in patients over 60 (p=0.043) but was not an independent prognostic factor in multivariate analysis (p=0.083).
Conclusions
- STAT3/p-STAT3 is upregulated in NSCLC and may serve as a potential biomarker.
- Further research is warranted to fully elucidate the role of STAT3/p-STAT3 in NSCLC prognosis.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

